zandelisib,me-401
mei,kyowa kirin
['tidal', 'zandelisib', 'mei pharma']
today, we are presenting new #zandelisib data from our ongoing tidal study at #asco22: 
We are committed to the development of novel, best-in-class, cancer therapies intended to provide improved outcomes to patients